Share Email Print

Optical Engineering

Transurethral microwave hyperthermia in benign prostatic hyperplasia
Author(s): Zbigniew P. Petrovich; Filip Ameye; Luc Baert
Format Member Price Non-Member Price
PDF $20.00 $25.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Benign prostatic hyperplasia (BPH) is a common disease affecting past middle-aged males. Surgical treatment has been successfully used since the early 1900s. Currently, nonsurgical treatment modalities are under intensive study in BPH patients who have relative contraindications to surgery. Transurethral microwave hyperthermia (TUHT) is one of these modalities under study. TUHT has been applied in five to ten treatment sessions. The treatments were well tolerated with no major toxicity being reported. In BPH patients with predominance of median lobe or median bar enlargement the treatment efficacy was reduced to 30%. The effectiveness of TUHT was of particular importance in patients who had urinary retention. In this group 72% had normal voiding for 12 months or longer. A strong correlation between applied temperature and response to treatment was demonstrated. Current efforts are directed toward optimization of technique and treatment schedule. A phase III prospective randomized trial is required to define the role of TUHT in the management of BPH patients.

Paper Details

Date Published: 1 September 1992
PDF: 5 pages
Opt. Eng. 31(9) doi: 10.1117/12.59906
Published in: Optical Engineering Volume 31, Issue 9
Show Author Affiliations
Zbigniew P. Petrovich, Univ. of Southern California (United States)
Filip Ameye, Univ. Hospital St. Pieter (Belgium)
Luc Baert, Catholic Univ. Leuven (Belgium)

© SPIE. Terms of Use
Back to Top